Skip to main content
Equibles
CLDX $31.01 -4.86%
CLDX logo
CLDX · Celldex Therapeutics, Inc.
Track CLDX — free

Use CLDX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CLDX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$31.01 -1.59 (-4.86%) At close · Oct 6
Russell 2000 member Rebalance outlook locked
Market Cap
$2.50B
Shares
78.53M
Volume · Oct 6 1.77M Avg daily vol (3M) 1.28M
All webcasts

Earnings call · FY2025 Q1

Celldex Therapeutics, Inc. (CLDX) Q1 2025 Earnings Call

Concluded May 8, 2025
May 8, 2025 0 turns
Period
FY2025 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $695,000 +345.5% YoY
Diluted EPS -$0.81
Net income -$53.80M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed May 8, 2025 10-Q report Filed May 8, 2025 Company webcastOpen the original investor-relations page

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Grant$645,000 +318.8% YoY
Service$50,000 +2400% YoY
Full-screen source Call document

CLDX transcript alerts

Celldex Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →